These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32900001)

  • 1. The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.
    Sobczak M; Zyma M; Robaszkiewicz A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32900001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PARP1 improves cardiac function after myocardial infarction via up-regulated NLRC5.
    Luo JM; Lin HB; Weng YQ; Lin YH; Lai LY; Li J; Li FX; Xu SY; Zhang HF; Zhao W
    Chem Biol Interact; 2024 May; 395():111010. PubMed ID: 38679114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP1-LSD1 functional interplay controls transcription of SOD2 that protects human pro-inflammatory macrophages from death under an oxidative condition.
    Tokarz P; Płoszaj T; Regdon Z; Virág L; Robaszkiewicz A
    Free Radic Biol Med; 2019 Feb; 131():218-224. PubMed ID: 30529301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis.
    Regdon Z; Robaszkiewicz A; Kovács K; Rygielska Ż; Hegedűs C; Bodoor K; Szabó É; Virág L
    Free Radic Biol Med; 2019 Feb; 131():184-196. PubMed ID: 30502458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation.
    Khan J; Sharma PK; Mukhopadhaya A
    Immunobiology; 2015 Nov; 220(11):1199-209. PubMed ID: 26093918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
    Zhen Y; Zhang Y; Yu Y
    Cell Rep; 2017 Nov; 21(8):2326-2337. PubMed ID: 29166620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxic effects of 1-nitropyrene in macrophages are mediated through a p53-dependent pathway involving cytochrome c release, caspase activation, and PARP-1 cleavage.
    Wu SW; Su CH; Ho YC; Huang-Liu R; Tseng CC; Chiang YW; Yeh KL; Lee SS; Chen WY; Chen CJ; Li YC; Lee CY; Kuan YH
    Ecotoxicol Environ Saf; 2021 Apr; 213():112062. PubMed ID: 33618169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention.
    Zhu X; Ma X; Hu Y
    Curr Med Chem; 2016; 23(17):1756-74. PubMed ID: 25245372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
    Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
    Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
    Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
    Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of poly(ADP-ribose) polymerase during neutrophilic and monocytic differentiation of promyelocytic (NB4) and myelocytic (HL-60) leukaemia cells.
    Bhatia M; Kirkland JB; Meckling-Gill KA
    Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):131-7. PubMed ID: 7755555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective].
    Wiśnik E; Ryksa M; Koter-Michalak M
    Postepy Hig Med Dosw (Online); 2016 Apr; 70():280-94. PubMed ID: 27117104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
    Jain PG; Patel BD
    Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response.
    Kim C; Wang XD; Yu Y
    Elife; 2020 Aug; 9():. PubMed ID: 32844745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.
    Shrestha E; Hussein MA; Savas JN; Ouimet M; Barrett TJ; Leone S; Yates JR; Moore KJ; Fisher EA; Garabedian MJ
    J Biol Chem; 2016 May; 291(21):11172-84. PubMed ID: 27026705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.